Harpreet Dhaliwal compensation by year
Vaxcyte Summary Compensation Table · the one fiscal year held| Component | FY2021 |
|---|---|
| Salary | $93,750 |
| Bonus | $15,000 |
| Stock awards | $0 |
| Option awards | $1,697,710 |
| Non-equity incentive | $37,734 |
| Pension and deferred compensation | $0 |
| All other | $0 |
| Total | $1,844,194 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Vaxcyte, Inc. DEF 14A filed April 20, 2022, accession 0001193125-22-111079, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Vaxcyte, Inc. filed document, accession 0001193125-22-111079. Every figure is read from that document and cited to the page and table it appears in. Filed April 20, 2022.
Insider transactions since the last proxy
21 Form 4 lines since the FY2021 proxy (filed April 20, 2022)current to 2026-11-21 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-11-11 | Sale | 10b5-1 | 520 | $68.82 | 68,085 |
| 2026-11-11 | Exercise or conversion derivative | 10b5-1 | 17,000 | $0.00 | 11,000 |
| 2026-11-11 | Sale | 10b5-1 | 9,345 | $68.16 | 68,605 |
| 2026-11-11 | Sale | 10b5-1 | 7,135 | $67.33 | 77,950 |
| 2026-11-11 | Exercise or conversion | 10b5-1 | 17,000 | $24.79 | 85,085 |
| 2026-09-08 | Tax withholding | — | 7,651 | $60.36 | 68,085 |
| 2026-09-02 | Tax withholding | — | 659 | $61.58 | 75,736 |
| 2026-08-31 | Tax withholding | — | 361 | $60.74 | 76,395 |
The 8 most recent of 21 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
Vaxcyte’s named executive officers, FY2021
as the company reported each| Named executive officer | Role | FY2021 total |
|---|---|---|
| Grant Pickering | Chief Executive Officer | $5,291,474 |
| Andrew Guggenhime | President and Chief Financial Officer | $2,753,001 |
| Jim Wassil | Executive Vice President and Chief Operating Officer | $1,970,336 |
| Harpreet Dhaliwal · this page | Senior Vice President, Commercial Manufacturing | $1,844,194 |
| Paul Sauer | Senior Vice President, Process Development and Manufacturing | $1,087,630 |
The full Vaxcyte compensation record
free company briefThis page is one person within Vaxcyte's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the Vaxcyte proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Vaxcyte's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.